期刊文献+

肝细胞癌组织中PTEN蛋白的表达以及与肝癌侵袭转移的关系 被引量:6

PTEN-protein Expression in Hepatocellular Carcinoma and its Association with Invasion and Metastasis
下载PDF
导出
摘要 目的研究人原发性肝癌(HCC)中的磷酸酶基因(PTEN基因)蛋白的表达及其临床意义。方法用免疫组织化学方法分别检测人HCC组织、癌旁组织中PTEN蛋白的表达情况。结果PTEN蛋白的表达在人HCC组织显著低于癌旁组织(P=0.038),其阳性率也显著低于癌旁肝组织(P=0.007)。PTEN蛋白的表达与HCC患者的年龄、血清AFP水平、肿瘤个数、肿瘤直径、临床分期、术后复发、有无肝外转移、病理分级等多数临床病理学指标无关,而与有无门脉癌栓有密切的关系。无门脉癌栓的患者的肝癌组织中的PTEN蛋白较有门脉癌栓的表达高(P=0.010)。结论HCC的发生中可能存在PTEN基因的突变或缺失。PTEN基因的表达缺失可能与HCC的恶性程度,疾病的进程及HCC的侵袭转移有密切关系。PTEN基因低表达,HCC患者病程较晚、肝癌的恶性程度较高,较容易发生侵袭转移,预后较差。 Objective To study PTEN-protein expression in primary human hepatocellular carcinoma (HCC) and its clinical significance. Methods PTEN-protein expression in HCC and paraneoplastic tissues was analyzed by Immunohistochemistry. Results PTEN-protein expression levels and positive rates were significantly lower in human HCC than in paraneoplastic tissues. PTEN protein expression was not related to most of the clinicopathological feathers,including age, serum AFP level, number of tumors, size of tumor, clinical stage, local recurrence, distant metastases, and pathological grade. PTEN protein expression was related to portal tumor thrombus. Patients without portal tumor thrombus had higher PTEN protein expression than those with portal tumor thrombus (P = 0.010). Conclusion PTEN gene mutation or loss of its expression may occur in the tumorogenesis of HCC. Loss of PTEN expression was closely related to the degree of malignancy of HCC, disease progression, and invasion and metastasis of HCC. Lower expression of PTEN tends to have more advanced disease, more maglinant tumor. Lower expression of PTEN is a negative prognostic factor.
出处 《实用癌症杂志》 2007年第3期263-265,共3页 The Practical Journal of Cancer
基金 广西科学基金资助(编号:03420106 530021)
关键词 肝细胞癌 磷酸酶基因蛋白 Hepatocellular carcinoma( HCC), Phosphatase and tensin homology deletedon chromosome ten (PTEN protein)
  • 相关文献

参考文献9

  • 1Knobbe CB,Trampe-Kieslich A,Reifenberger G.Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas[J].Neuropathol Appl Neurobiol,2005,31(5):486.
  • 2Slipicevic A,Holm R,Nguyen MT,et al.Expression of activated Akt and PTEN in malignant melanomas:relationship with clinical outcome[J].Am J Clin Pathol,2005,124(4):528.
  • 3吕庆杰,赵晓东,宋继谒,李晓晗,马颖,孟辉,姜卫国.卵巢癌PTEN基因失活机制的探讨[J].中华病理学杂志,2005,34(5):266-269. 被引量:15
  • 4Knobbe CB,Trampe-Kieslich A,Reifenberger G.Genetic alteration and expression of the phosphoinositol-3-kinase/Akt pathway genes PIK3CA and PIKE in human glioblastomas[J].Neuropathol Appl Neumbiol,2005,31(5):486.
  • 5HuTH,Huang C C,Lin P R,et al.Expression and prognosticrole of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma[J].Cancer,2003,97(8):1929.
  • 6Tamura M,Gu J,Mat sumoto K,et al.Inhibition of cell migration spreading and focal adhesion by tumor suppressor PTEN[J].Sciense,1998,280(9):1614.
  • 7Di Cristofano A,Pandolfi P P.The multiple roles of PTEN in tumor suppression[J].Cell,2000,100(4):387.
  • 8Kannagi R,Izawa M,Koike T,et al.Carbohydrate-mediated celladhesion in cancer metastasis and angiogenesis[J].Cancer Sci,2004,95(5):377.
  • 9Wu RC,Li X,Schonthal AH.Transcrip tional activation of p21 WAF1 by PTEN/MMAC1 tumor supp ressor[J].Mol Cell Biochem,2000,203(1-2):59.

二级参考文献14

  • 1Sato N, Tsunoda H, Nishida M, et al. Loss of heterozygosity on 10q23.3 and mutation of the tumor suppressor gene PTEN in benign endometrial cyst of the ovary: possible sequence progression from benign endometrial cyst to endometrioid carcinoma and clear cell carcinoma of the ovary. Cancer Res, 2000, 60: 7052-7056.
  • 2Sano T, Lin H, Chen X, et al. Differential expression of MMAC/PTEN in glioblastoma multiforme: relationship to localization and prognosis. Cancer Res, 1999,59:1820-1824.
  • 3Tashiro H, Blazes MS, Wu R, et al. Mutations in PTEN are frequent in endometrial carcinoma but rare in other common gynecological malignancies. Cancer Res, 1997, 57: 3935-3940.
  • 4Saito M, Okamoto A, Kohno T, et al. Allelic imbalance and mutations of the PTEN gene in ovarian cancer. Int J Cancer, 2000, 85: 160-165.
  • 5Kurose K, Zhou XP, Araki T, et al. Frequent loss of PTEN expression is linked to elevated phosphorylated Akt levels, but not associated with p27 and cyclin D1 expression, in primary epithelial ovarian carcinomas. Am J Pathol, 2001, 158: 2097-2106.
  • 6Schondorf T, Hoopmann M, Eversheim B, et al. Expression of the tumor suppressor gene PTEN is not altered in the progression of ovarian carcinomas and does not correlate with p27Kip1 expression. Oncol Rep, 2003,10:1717-1722.
  • 7Reis RM, Konu-Lebleblicioglu D, Lopes JM, et al. Genetic profile of gliosarcomas. Am J Pathol, 2000, 156: 425-432.
  • 8Kurose K, Zhou XP, Araki T, et al. Biallelic inactivating mutations and an occult germline mutation of PTEN in primary cervical carcinomas. Genes Chromosomes Cancer, 2000, 29: 166-172.
  • 9Zhou XP, Gimm O, Hampel H, et al. Epigenetic PTEN silencing in malignant melanomas without PTEN mutation. Am J Pathol, 2000, 157: 1123-1128.
  • 10Gimm O, Perren A, Weng LP, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am J Pathol, 2000, 156: 1693-1700.

共引文献14

同被引文献39

引证文献6

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部